Dysfunctional fat cells, lipotoxicity and type 2 diabetes - PubMed (original) (raw)

Review

Dysfunctional fat cells, lipotoxicity and type 2 diabetes

R A DeFronzo. Int J Clin Pract Suppl. 2004 Oct.

Abstract

Type 2 diabetes is characterized by insulin resistance and impaired insulin secretion. Considerable evidence implicates altered fat topography and defects in adipocyte metabolism in the pathogenesis of type 2 diabetes. In individuals who develop type 2 diabetes, fat cells tend to be enlarged. Enlarged fat cells are resistant to the antilipolytic effects of insulin, leading to day-long elevated plasma free fatty acid (FFA) levels. Chronically increased plasma FFA stimulates gluconeogenesis, induces hepatic and muscle insulin resistance, and impairs insulin secretion in genetically predisposed individuals. These FFA-induced disturbances are referred to as lipotoxicity. Enlarged fat cells also have diminished capacity to store fat. When adipocyte storage capacity is exceeded, lipid 'overflows' into muscle and liver, and possibly the beta-cells of the pancreas, exacerbating insulin resistance and further impairing insulin secretion. In addition, dysfunctional fat cells produce excessive amounts of insulin resistance-inducing, inflammatory and atherosclerosis-provoking cytokines, and fail to secrete normal amounts of insulin-sensitizing cytokines. As more evidence emerges, there is a stronger case for targeting adipose tissue in the treatment of type 2 diabetes. Peroxisome-proliferator activated receptor gamma (PPARgamma) agonists, for example the thiazolidinediones, redistribute fat within the body (decrease visceral and hepatic fat; increase subcutaneous fat) and have been shown to enhance adipocyte insulin sensitivity, inhibit lipolysis, reduce plasma FFA and favourably influence the production of adipocytokines. This article examines in detail the role of adipose tissue in the pathogenesis of type 2 diabetes and highlights the potential of PPAR agonists to improve the management of patients with the condition.

PubMed Disclaimer

Similar articles

• Lipid Storage, Lipolysis, and Lipotoxicity in Obesity.
  Engin A. Engin A. Adv Exp Med Biol. 2024;1460:97-129. doi: 10.1007/978-3-031-63657-8_4. Adv Exp Med Biol. 2024. PMID: 39287850 Review.
• Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying actions of the thiazolidinediones.
  Smith SA. Smith SA. Biochimie. 2003 Dec;85(12):1219-30. doi: 10.1016/j.biochi.2003.10.010. Biochimie. 2003. PMID: 14739074 Review.
• Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage.
  Raz I, Eldor R, Cernea S, Shafrir E. Raz I, et al. Diabetes Metab Res Rev. 2005 Jan-Feb;21(1):3-14. doi: 10.1002/dmrr.493. Diabetes Metab Res Rev. 2005. PMID: 15386813 Review.
• Mechanism of Obesity-Related Lipotoxicity and Clinical Perspective.
  Engin AB. Engin AB. Adv Exp Med Biol. 2024;1460:131-166. doi: 10.1007/978-3-031-63657-8_5. Adv Exp Med Biol. 2024. PMID: 39287851 Review.
• Rosiglitazone ameliorates skeletal muscle insulin resistance by decreasing free fatty acids release from adipocytes.
  Gong L, Jin H, Li Y, Quan Y, Yang J, Tang Q, Zou Z. Gong L, et al. Biochem Biophys Res Commun. 2020 Dec 17;533(4):1122-1128. doi: 10.1016/j.bbrc.2020.09.144. Epub 2020 Oct 6. Biochem Biophys Res Commun. 2020. PMID: 33036752

Cited by

• Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas.
  Souza-Tavares H, Miranda CS, Vasques-Monteiro IML, Sandoval C, Santana-Oliveira DA, Silva-Veiga FM, Fernandes-da-Silva A, Souza-Mello V. Souza-Tavares H, et al. World J Gastroenterol. 2023 Jul 14;29(26):4136-4155. doi: 10.3748/wjg.v29.i26.4136. World J Gastroenterol. 2023. PMID: 37475842 Free PMC article. Review.
• The CEACAM1 expression is decreased in the liver of severely obese patients with or without diabetes.
  Lee W. Lee W. Diagn Pathol. 2011 May 11;6:40. doi: 10.1186/1746-1596-6-40. Diagn Pathol. 2011. PMID: 21569294 Free PMC article.
• Relative contribution of adipose triglyceride lipase and hormone-sensitive lipase to tumor necrosis factor-α (TNF-α)-induced lipolysis in adipocytes.
  Yang X, Zhang X, Heckmann BL, Lu X, Liu J. Yang X, et al. J Biol Chem. 2011 Nov 25;286(47):40477-85. doi: 10.1074/jbc.M111.257923. Epub 2011 Oct 3. J Biol Chem. 2011. PMID: 21969372 Free PMC article.
• Obesity-related parameters in carriers of some BDNF genetic variants may depend on daily dietary macronutrients intake.
  Miksza U, Adamska-Patruno E, Bauer W, Fiedorczuk J, Czajkowski P, Moroz M, Drygalski K, Ustymowicz A, Tomkiewicz E, Gorska M, Kretowski A. Miksza U, et al. Sci Rep. 2023 Apr 21;13(1):6585. doi: 10.1038/s41598-023-33842-4. Sci Rep. 2023. PMID: 37085692 Free PMC article.
• Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol.
  Den Hartogh DJ, Tsiani E. Den Hartogh DJ, et al. Biomolecules. 2019 Mar 12;9(3):99. doi: 10.3390/biom9030099. Biomolecules. 2019. PMID: 30871083 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program